Nordic Neurodegeneration Biotech Companies

Overview

Overview

The Nordic countries have a growing biotechnology sector focused on developing treatments for neurodegenerative diseases. Sweden in particular has a strong tradition in neuroscience research, with companies developing innovative therapies for Alzheimer's, Parkinson's, and other neurodegenerative conditions.

Swedish Companies

BioArctic AB

BioArctic AB is a Swedish biopharma company focused on developing novel treatments for Alzheimer's disease.

• Headquarters: Stockholm, Sweden
• Focus: Alzheimer's disease, Parkinson's disease
• Key programs:
• BAN2401 (lecanemab) - [Amyloid-beta](/proteins/amyloid-beta) antibody (partnered with Eisai)
• ABBV-0805 - [Tau](/proteins/tau) antibody for PSP (formerly Novanano)
• [Alpha-synuclein](/proteins/alpha-synuclein) antibodies for PD
• Status: Clinical trials

Araize AB

Araize is a Swedish biotech developing RNA-based therapies for neurodegenerative diseases.

• Headquarters: Stockholm
• Focus: Alzheimer's disease
• Approach: RNA interference
• Status: Preclinical

2A Pharma AB

2A Pharma is a Swedish company focused on developing drugs for neurological disorders.

• Headquarters: Lund, Sweden
• Focus: Neurodegeneration
• Approach: Novel small molecules
• Status: Research

Lipigon Pharmaceuticals

Lipigon is a Swedish biotech developing therapies for lipid-related diseases including neurodegeneration.

• Headquarters: Umeå, Sweden
• Focus: Lipid metabolism in neurodegeneration
• Approach: RNA-based therapeutics
• Status: Preclinical

Obsidian Therapeutics (Swedish operations)

Obsidian has operations in Sweden focused on tumor microenvironment and neuroimmunology.

• Headquarters: US (with Stockholm operations)
• Focus: Neuroimmunology
• Approach: Immunomodulation

Norwegian Companies

Neurodegeneration Research Norway

Norwegian research groups focused on neurodegenerative disease research:

• Oslo University Hospital: Parkinson's research
• University of Bergen: Tau research
• NTNU: Neuroprotection studies

Spinco Biotech

Spinco is a Norwegian biotech developing treatments for neurological disorders.

• Headquarters: Oslo, Norway
• Focus: Parkinson's disease
• Approach: Novel small molecules
• Status: Research

NNeuro AS

NNeuro is a Norwegian company focused on nerve regeneration.

• Headquarters: Trondheim, Norway
• Focus: Neuroprotection
• Approach: Neurotrophic factors
• Status: Preclinical

Danish Companies

Lundbeck

H. Lundbeck is a major Danish pharmaceutical company with significant neuroscience R&D.

• Headquarters: Copenhagen, Denmark
• Focus: Alzheimer's disease, Parkinson's disease, ALS, depression
• Key programs:
• Lu AF20513 - Alzheimer's vaccine
• Tau research programs
• Status: Various clinical trials

Gubra

Gubra is a Danish contract research organization with neuroscience expertise.

• Headquarters: Copenhagen, Denmark
• Focus: CNS drug development
• Approach: Preclinical research services

Synaptic

Synaptic is a Danish company focused on synaptic function in neurodegeneration.

• Headquarters: Copenhagen
• Focus: Synaptic dysfunction
• Approach: Novel targets

Osisco

Osisco is a Danish biotech developing treatments for CNS disorders.

• Focus: Alzheimer's disease
• Approach: Small molecules

Finnish Companies

Herantis Pharma

Herantis is a Finnish biotech focused on Parkinson's disease and other neurodegenerative conditions.

• Headquarters: Helsinki, Finland
• Focus: Parkinson's disease
• Key programs:
• Herantis-001 - CDNF-based therapy for PD
• AAV-based gene therapy
• Status: Clinical trials

NextCyte

NextCyte is a Finnish company developing cell therapy approaches.

• Focus: Neurodegeneration
• Approach: Cell replacement

Finnish Neuroscience Companies

• University of Helsinki: Neurodegeneration research
• University of Turku: Alzheimer's research
• Aalto University: Neurotechnology

Research Institutions

Sweden

• Karolinska Institute: World-renowned neuroscience research
• Uppsala University: Neurobiology
• Lund University: Brain research

Norway

• University of Oslo: neuroscience
• Norwegian University of Science and Technology (NTNU)

Denmark

• Copenhagen University: Neuroscience center
• Danish Dementia Research Centre

Finland

• University of Helsinki: Neuroscience
• Institute for Molecular Medicine Finland

Funding and Ecosystem

Nordic Innovation

• Nordic Council: Biotech funding programs
• Venture capital: Nordic VC firms investing in neurodegeneration

EU Funding

• Horizon Europe: Neuroscience research programs
• European Innovation Council: Biotech funding

Clinical Trial Sites

Major trials in the Nordic region:

• Karolinska Institute (Sweden)
• Copenhagen University Hospital (Denmark)
• Oslo University Hospital (Norway)
• Helsinki University Hospital (Finland)

See Also

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
• [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)

References